Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia

  1. Sanchez-Garcia, J.
  2. Falantes, J.
  3. Medina Perez, A.
  4. Hernandez-Mohedo, F.
  5. Hermosin, L.
  6. Torres-Sabariego, A.
  7. Bailen, A.
  8. Hernandez-Sanchez, J.M.
  9. Solé Rodriguez, M.
  10. Casaño, F.J.
  11. Calderon, C.
  12. Labrador, M.
  13. Vahí, M.
  14. Serrano, J.
  15. Lumbreras, E.
  16. Hernández-Rivas, J.M.
Revue:
Leukemia and Lymphoma

ISSN: 1029-2403 1042-8194

Année de publication: 2018

Volumen: 59

Número: 5

Pages: 1095-1104

Type: Article

DOI: 10.1080/10428194.2017.1366998 GOOGLE SCHOLAR

Objectifs de Développement Durable